Big Pharma’s business-as-usual playbook relies on egregious pricing practices and rhetoric designed to set and keep drug prices high.

Drug prices in the United States are out of control as a direct result of the egregious pricing and anti-competitive practices of brand name pharmaceutical companies. Rising prescription drug prices threaten the affordability of our health care system, the long-term health of our nation and the vitality of our entire economy. Public opinion research finds as many as one-in-three Americans experience financial difficulty, either as a patient themselves or through a family member, affording prescription drugs. CSRxP has developed market-based solutions to restore a functioning market and lower prices for patients by increasing list price transparency, promoting competition and actual innovation and focusing on better value for patients, not better value for pharmaceutical companies.

May 13, 2025

CSRxP STATEMENT ON PRESIDENT TRUMP’S MOST FAVORED NATION EXECUTIVE ORDER

Administration Rightly Diagnoses Big Pharma’s Egregious Pricing Practices as Root

May 13, 2025

THEY SAID IT! RFK JR CALLS FOR REINING IN BIG PHARMA’S STAGGERING SPENDING ON DTC ADVERTISING OF PRESCRIPTION DRUGS

HHS Secretary Highlights How Big Pharma’s Marketing Strategies for High-Priced Brand

May 8, 2025

BIG PHARMA EARNINGS WATCH: NOVO NORDISK

Brand Name Manufacturer Previews New DTC Ad Campaign to Further Boost Sales of

May 5, 2025

BIG PHARMA EARNINGS WATCH: AMGEN AND ELI LILLY

Pharmaceutical Companies Continue Reporting Big Time Earnings While Continuing to Hike

May 13, 2025

CSRxP STATEMENT ON PRESIDENT TRUMP’S MOST FAVORED NATION EXECUTIVE ORDER

Administration Rightly Diagnoses Big Pharma’s Egregious Pricing Practices as Root

May 13, 2025

THEY SAID IT! RFK JR CALLS FOR REINING IN BIG PHARMA’S STAGGERING SPENDING ON DTC ADVERTISING OF PRESCRIPTION DRUGS

HHS Secretary Highlights How Big Pharma’s Marketing Strategies for High-Priced Brand

May 8, 2025

BIG PHARMA EARNINGS WATCH: NOVO NORDISK

Brand Name Manufacturer Previews New DTC Ad Campaign to Further Boost Sales of

May 5, 2025

BIG PHARMA EARNINGS WATCH: AMGEN AND ELI LILLY

Pharmaceutical Companies Continue Reporting Big Time Earnings While Continuing to Hike

Videos

Watch and learn about Big Pharma’s price-gouging techniques that are the cause of out-of-control drug prices.

Fact Sheets

Get the facts on Big Pharma’s anti-competitive tactics, like price-gouging and patent abuse that keeps drug prices high.

Infographics

Learn about how Big Pharma is driving the Rx drug pricing crisis with our infographics.

Polling

See recent surveys on American voters’ opinions on Big Pharma’s blame game and out-of-control drug pricing.

Join us in telling lawmakers: It’s time to hold Big Pharma accountable and lower Rx drug prices.

By signing your name, you are opting-in to receive calls and SMS/MMS messages, including autodialed and automated calls and texts, to that number from CSRxP. Msg & data rates may apply.
This field is for validation purposes and should be left unchanged.